Modified Story Memory Technique (mSMT) in Persons With TBI
NCT ID: NCT04056312
Last Updated: 2023-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2016-06-29
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. test the efficacy of the group based mSMT in persons with TBI on NPE, the current gold-standard for measuring memory functioning
2. assess the effectiveness of the group mSMT on more global measures of everyday life, including an objective measure shown through our previous work to be sensitive to memory changes following the mSMT, as well as additional questionnaires to be completed by both the participant and a significant other
3. evaluate the changes in brain functioning following treatment with the mSMT via fMRI and
4. evaluate the long-term effects of the treatment protocol.
To accomplish these goals investigators will conduct a double-blind, placebo-controlled, RCT, applying the group mSMT to a sample of 60 participants with moderate to severe TBI (30 treatment; 30 control).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strategy Based Technique to Enhance Memory (STEM) for Improving New Learning and Memory (NLM) in Moderate to Severe TBI
NCT04054596
Application of the Modified Story Memory Technique (mSMT)© to Aging
NCT03370224
Improving New Learning and Memory in School Aged Children
NCT04741360
Improving New Learning and Memory in Traumatic Brain Injury
NCT01207375
Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS
NCT03983681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group memory retraining
Experimental group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.
Group Memory retraining exercises
Experimental group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.
Placebo
Experimental group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.
Placebo controlled group memory exercise training
Placebo group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group Memory retraining exercises
Experimental group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.
Placebo controlled group memory exercise training
Placebo group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* I have had a Traumatic Brain Injury at least one year ago.
* I can read and speak English fluently.
* I have difficulties with learning and memory skills.
Exclusion Criteria
* I have had a prior stroke or neurological injury/disease other than a traumatic brain injury.
* I have a history of significant psychiatric illness (for example, bipolar disorder or psychosis) or a current diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder I or II.
* I have unstable or uncontrolled seizures.
* I have a significant alcohol or drug abuse history.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kessler Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nancy Chiaravalloti
Director NNL & TBI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Green, PhD
Role: STUDY_CHAIR
Kessler Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kessler Foundation
West Orange, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R-926-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.